Focus Taiwan App
Download

Adimmune affirms quality of eggs used for H1N1 vaccine production

12/24/2009 05:25 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taiwan's vaccine manufacturer Adimmune Corp. gave the assurance Thursday that there was no problem with the quality of eggs used to produce the influenza A(H1N1) vaccine, amid suspicion that contaminated eggs could have been responsible for the severe side effects suffered by some individuals who have received the vaccine. 


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    23